Cardinal Health (CAH) Expected to Post Earnings on Thursday

Cardinal Health (NYSE:CAH) is projected to release its Q1 2027 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $2.94 per share and revenue of $66.67 billion for the quarter. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Parties can check the company’s upcoming Q1 2027 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. During the same period last year, the business earned $2.08 earnings per share. Cardinal Health’s quarterly revenue was up 5.8% on a year-over-year basis. On average, analysts expect Cardinal Health to post $12.55 EPS for the current fiscal year and $13.91 EPS for the next fiscal year.

Cardinal Health Trading Down 0.4%

Shares of NYSE:CAH opened at $253.32 on Wednesday. Cardinal Health has a 12-month low of $180.45 and a 12-month high of $259.84. The company has a market capitalization of $58.66 billion, a PE ratio of 35.04, a PEG ratio of 1.53 and a beta of 0.53. The business has a 50 day moving average of $238.67 and a two-hundred day moving average of $222.72.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were paid a dividend of $0.5158 per share. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

Insider Activity at Cardinal Health

In other news, insider Jessica L. Mayer sold 29,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the sale, the insider directly owned 33,076 shares in the company, valued at $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michelle D. Greene sold 11,650 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the sale, the insider owned 10,330 shares of the company’s stock, valued at $2,434,987.60. This trade represents a 53.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 in the last ninety days. 0.12% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CAH. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Evercore reissued an “outperform” rating and set a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Barclays increased their price target on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Morgan Stanley raised their price target on shares of Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. Finally, Mizuho lifted their price objective on shares of Cardinal Health from $250.00 to $280.00 and gave the company an “outperform” rating in a report on Tuesday, October 20th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $270.69.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.